Date: Feb 26, 2022 10:00 AM - 11:00 AM
Registration closes on Apr 09, 2022 01:00 AM
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- Recognize existing and novel therapeutic options for mild-moderate COVID patients
- Recall important characteristics of phase III trials of novel therapeutic options
- Identify NIH guidelines to recommend appropriate therapeutic options for mild-moderate COVID & HIV patients
Andrew A. Yabusaki, PharmD, BCPS, RPh